Abstract
Purpose
Cesarean scar pregnancy (CSP) remains a sporadic form of ectopic pregnancy associated with a severe life-threatening condition. There is no consensus on the treatment modality or a generally accepted guideline in CSP. This study aims to evaluate the outcomes of the different treatment modalities used in CSP treatment at a single center, as well as a literature review.
Methods
This is a retrospective case series study that was conducted; all women who diagnosed with CSP between January 2013 and November 2019 at Women's Specialized Hospital, King Fahad Medical City. The clinical characteristics, diagnosis, different treatment modalities, and clinical outcomes were analyzed.
Results
Twenty-seven cases of CSP identified during the study period. The median maternal age was 38 years (range 23–47 years). The gestational age at diagnosis ranged between 5 weeks and 5 days to 13 weeks and 6 days. All diagnoses were made by ultrasound. The absence of embryonic cardiac activity was seen in 10 cases (37.03%). The most commonly used method for first-line treatment was medical treatment. A total of 14 patients (51.85%) were treated with systemic methotrexate (MTX), three (11.1%) intra-sac and systemic MTX, and two (7.4%) intra-cardiac potassium chloride (KCl) along with systemic MTX, five (18.51%) cases had expectant management, one case initially treated with Laparotomy Wedge resection, and one case treated with uterine artery embolization (UAE) and systemic MTX. A total of 20 (74.07%) patients were treated successfully with first-line treatment. Seven (25.92%) patients needed additional second-line treatment. Among them, only one case had surgical intervention. None of the women in the medical treatment group experienced any side effects. Based on ANOVA results, there is no considerable relationship between the mean time of resolution of β-hCG and four treatment modalities for CSP (p = 0.2406). There was no statistical significance when the fetal viability at the time of diagnosis was compared to the need for second-line treatment of CSP (p = 0.58).
Conclusion
The treatment of CSP should be individualized based on risk factors. Diagnosis and management of CSP need expertise and a multidisciplinary approach to prevent complications. Early diagnosis and management of cesarean scar ectopic pregnancy remains the mainstay for a successful outcome.
Similar content being viewed by others
Abbreviations
- CSP:
-
Cesarean scar pregnancy
- MTX:
-
Methotrexate
- BMI:
-
Body mass index
- β-HCG:
-
Beta human chorionic gonadotrophin
- MRI:
-
Magnetic resonance imaging
- UAE:
-
Uterine artery embolization
References
Fylstra DL (2002) Ectopic pregnancy within a cesarean scar: a review. Obstet Gynecol Surv 57:537–543
Maymon R, Halperin R, Mendlovic S, Schneider D, Herman A (2004) Ectopic pregnancies in a Caesarean scar: review of the medical approach to an iatrogenic complication. Hum Reprod Update 10(6):515–523
Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ (2003) First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol 21:220–227
Lai YM, Lee JD, Lee CL et al (1995) Ectopic pregnancy embedded in the myometrium of a previous cesarean section scar. Acta Obstet Gynecol Scand 74:573–576
Rotas MA, Haberman S, Levgur M (2006) Cesarean scar ectopic pregnancies: etiology, diagnosis and management. Obstet Gynecol 107(6):1373–1381
Petrides A, Dinglas C, Chavez M, Taylor S, Mahboob S (2016) Revisiting ectopic pregnancy : a pictorial essay. J Clin Imaging Sci 4(3):1–6
Ash A, Smith A, Maxwell D (2007) Caesarean scar pregnancy. BJOG 114(3):253–263
Sinha P, Mishra MJ (2012) Caesarean scar pregnancy: a precursor of placenta percreta/accreta. J Obstet Gynaecol 32:621–623
Devarajan S, Datta S (2014) Caesarean scar ectopic pregnancy. Obstet Gynaecol Reprod Med 24:153
Seow K, Huang L, Lin Y et al (2004) Cesarean scar pregnancy: issues in management. Ultrasound Obstet Gynecol 23(3):247–253
Ouyang Y, Li X, Yi Y, Gong F, Lin G, Lu G (2015) First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases. Reprod Biol Endocrinol 13:126
Vial Y, Petignat P, Hohlfeld P (2000) Ultrasound Obstet Gynecol 16(6):592–593
Zhang Y, Gu Y, Wang JM, Li Y (2013) Analysis of cases with cesarean scar pregnancy. J Obstet Gynaecol Res 39:195–202
Timor-Tritsch IE, Monteagudo A, Santos R, Tsymbal T, Pineda G, Arslan AA (2012) The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol 207:244
El Guindi W, Alalfy M, Abasy A, Ellithy A, Nabil A, Abdalfatah O et al (2013) A report of four cases of caesarean scar pregnancy in a period of 24 months. J Med Diagn Methods 2:2
Jayaram PM, Okunoye GO, Konje J (2017) Caesarean scar ectopic pregnancy: diagnostic challenges and management options. Obstet Gynecol 19:13–20
Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J et al (2018) Outcome of cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 51(2):169–175
Bodur S, Özdamar Ö, Kılıç S et al (2015) The efficacy of the systemic methotrexate treatment in caesarean scar ectopic pregnancy: a quantitative review of English literature. J Obstet Gynaecol 35(3):290–296
Godin PA, Bassil S, Donnez J (1997) An ectopic pregnancy developing in a previous caesarian section scar. Fertil Steril 67:398–400
Timor-Tritsch IE, Monteagudo A (2012) Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review. Am J Obstet Gynecol 207:14–29
Wu R, Klein M, Mahboob S, Gupta M et al (2013) Magnetic resonance imaging as an adjunct to ultrasound in evaluating cesarean scar ectopic pregnancy. J Clin Imaging Sci 3:16
Fylstra DL, Pound-Chang T, Grant MM, Cooper A, Miller KM (2002) Ectopic pregnancy within a cesarean delivery scar: a case report. Am J Obstet Gynecol 187:302–304
Wu X, Zhang X, Zhu J et al (2012) Caesarean scar pregnancy: comparative efficacy and safety of treatment by uterine artery chemoembolization and systemic methotrexate injection. Eur J Obstet Gynecol Reprod Biol 161:75–79
Shen L, Tan A, Zhu H et al (2012) Bilateral uterine artery chemoembolization with methotrexate for cesarean scar pregnancy. Am J Obstet Gynecol 207(386):e1-6
Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre NH (2016) Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril 105:958–967
Funding
No external funding was used in this conduct of this study.
Author information
Authors and Affiliations
Contributions
All authors have contributed to conception and design of the study, drafting the article, revising it critically for important intellectual content. All authors have approved the final article.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board committee in king Fahad medical city (Approval No.19-661).
Informed consent
For this type of study, formal consent is not required and was waived by the institutional review board approval.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al-Jaroudi, D., Aboudi, S. & Baradwan, S. Different treatment modalities for cesarean scar pregnancies: a single-center experience and literature review. Arch Gynecol Obstet 303, 1143–1151 (2021). https://doi.org/10.1007/s00404-020-05831-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05831-9